sarepta srpt - Search News

Order byBest matchMost fresh

News

Sarepta to continue Elevidys shipments

Sarepta Therapeutics Announces Voluntary Pause of ELEVIDYS Shipments in the U.S.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement:

Continue reading

· 50m · on MSN

Sarepta to pause gene therapy Elevidys shipments in US

· 14h · on MSN

Sarepta extends losses premarket after refusing FDA’s halt request

FDA Shuts Down Sarepta Gene Therapy Trials

Zacks Investment Research on M… · 9h

SRPT Down After Third Death in Muscular Dystrophy Gene Therapy Program

Shares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its experimental gene therapies. The company confirmed that a 51-year-old, non-ambulant (unable to walk) limb-girdle muscular dystrophy (LGMD) patient died due to acute liver failure (ALF).

Continue reading

FDA Places Sarepta's Investigational Gene-Therapy Trials on Hold Following Patient Death

MyChesCo on MSN · 7h

FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver Failure

12h

Sarepta Therapeutics: Why Is SRPT Stock Crashing?

The FDA has placed multiple investigational gene therapy clinical trials on hold, signaling broader platform concerns.

8h

Sarepta Therapeutics stock sinks after FDA tells company to stop shipping its bestselling drug

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an ...

Fintel on MSN12h

Needham Downgrades Sarepta Therapeutics (SRPT)

Fintel reports that on July 21, 2025, Needham downgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Hold to ...

15hon MSN

Sarepta stock extends decline as company declines FDA call to withdraw drug

Sarepta Therapeutics traded lower on Monday, extending a slide as the company took the unusual step of refusing a Food and ...

4d

Sarepta Therapeutics: What's Happening With SRPT Stock?

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results